Home > Healthcare > Medical Devices > Therapeutic Devices > Diabetes Care Devices Market
The global diabetes care devices market size was valued at around USD 45.1 billion in 2023 and is estimated to grow at 11.4% CAGR from 2024 to 2032. Diabetes care devices refer to a range of medical tools designed to monitor, manage, and treat diabetes. These devices include blood glucose meters, continuous glucose monitors (CGMs), insulin pumps, smart insulin pens, syringes, and lancets, each serving a critical role in helping individuals maintain optimal blood sugar levels and manage insulin therapy effectively.
The growing prevalence of diabetes across the world is the primary factor propelling the diabetes care devices market growth. For instance, according to the World Health Organization (WHO), in 2024, approximately 422 million people worldwide have diabetes, with the majority residing in low- and middle-income countries. Additionally, 1.5 million deaths are directly attributed to diabetes each year. This increasing incidence of diabetes is anticipated to fuel demand for effective management solutions, including continuous glucose monitoring, and insulin delivery devices. Consequently, this demand is likely to drive advancements in diabetes care devices to improve patient outcomes and enhance disease management.
Moreover, the market growth is driven by rising technological advancements in diabetes care devices and increasing investments by public and private organizations for diabetes care.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Diabetes Care Devices Market Size in 2023: | USD 45.1 Billion |
Forecast Period: | 2024 – 2032 |
Forecast Period 2024 – 2032 CAGR: | 11.4% |
2024 – 2032 Value Projection: | USD 118.6 Billion |
Historical Data for: | 2021 - 2023 |
No. of Pages: | 145 |
Tables, Charts & Figures: | 324 |
Segments covered: | Product, End Use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|